Table of Contents

1 Report Overview

• 1.1 Study Scope
• 1.2 Major Manufacturers Covered in This Report
• 1.3 Market Segment by Type
  • 1.3.1 Global Oral Solid Dosage Pharmaceutical Formulation Market Size Growth Rate by Type (2019-2025)
  • 1.3.2 Immediate Release
  • 1.3.3 Extended Release
  • 1.3.4 Others
• 1.4 Market Segment by Application
  • 1.4.1 Global Oral Solid Dosage Pharmaceutical Formulation Market Share by Application (2019-2025)
  • 1.4.2 Hospital Pharmacy
  • 1.4.3 Retail Pharmacy
  • 1.4.4 Drug Stores
  • 1.4.5 Others
• 1.5 Study Objectives
• 1.6 Years Considered

2 Global Growth Trends

• 2.1 Global Oral Solid Dosage Pharmaceutical Formulation Market Size
  • 2.1.1 Global Oral Solid Dosage Pharmaceutical Formulation Revenue 2014-2025
  • 2.1.2 Global Oral Solid Dosage Pharmaceutical Formulation Sales 2014-2025
• 2.2 Oral Solid Dosage Pharmaceutical Formulation Growth Rate by Regions
  • 2.2.1 Global Oral Solid Dosage Pharmaceutical Formulation Sales by Regions 2014-2019
  • 2.2.2 Global Oral Solid Dosage Pharmaceutical Formulation Revenue by Regions 2014-2019
• 2.3 Industry Trends
  • 2.3.1 Market Top Trends
  • 2.3.2 Market Drivers

3 Market Share by Manufacturers

• 3.1 Oral Solid Dosage Pharmaceutical Formulation Sales by Manufacturers
  • 3.1.1 Oral Solid Dosage Pharmaceutical Formulation Sales by Manufacturers 2014-2019
  • 3.1.2 Oral Solid Dosage Pharmaceutical Formulation Sales Market Share by Manufacturers 2014-2019
• 3.2 Revenue by Manufacturers
  • 3.2.1 Oral Solid Dosage Pharmaceutical Formulation Revenue by Manufacturers (2014-2019)
  • 3.2.2 Oral Solid Dosage Pharmaceutical Formulation Revenue Share by Manufacturers (2014-2019)
  • 3.2.3 Global Oral Solid Dosage Pharmaceutical Formulation Market Concentration Ratio (CR5 and HHI)
• 3.3 Oral Solid Dosage Pharmaceutical Formulation Price by Manufacturers
• 3.4 Key Manufacturers Oral Solid Dosage Pharmaceutical Formulation Plants/Factories Distribution and Area Served
• 3.5 Date of Key Manufacturers Enter into Oral Solid Dosage Pharmaceutical Formulation Market
• 3.6 Key Manufacturers Oral Solid Dosage Pharmaceutical Formulation Product Offered
• 3.7 Mergers & Acquisitions, Expansion Plans

4 Market Size by Type

• 4.1 Sales and Revenue for Each Type
  • 4.1.1 Immediate Release Sales and Revenue (2014-2019)
  • 4.1.2 Extended Release Sales and Revenue (2014-2019)
  • 4.1.3 Others Sales and Revenue (2014-2019)
• 4.2 Global Oral Solid Dosage Pharmaceutical Formulation Sales Market Share by Type
• 4.3 Global Oral Solid Dosage Pharmaceutical Formulation Revenue Market Share by Type
• 4.4 Oral Solid Dosage Pharmaceutical Formulation Price by Type

5 Market Size by Application

• 5.1 Overview
• 5.2 Global Oral Solid Dosage Pharmaceutical Formulation Sales by Application

6 United States

• 6.1 United States Oral Solid Dosage Pharmaceutical Formulation Breakdown Data by Company
• 6.2 United States Oral Solid Dosage Pharmaceutical Formulation Breakdown Data by Type
• 6.3 United States Oral Solid Dosage Pharmaceutical Formulation Breakdown Data by Application

7 European Union

• 7.1 European Union Oral Solid Dosage Pharmaceutical Formulation Breakdown Data by Company
• 7.2 European Union Oral Solid Dosage Pharmaceutical Formulation Breakdown Data by Type
• 7.3 European Union Oral Solid Dosage Pharmaceutical Formulation Breakdown Data by Application

8 China

• 8.1 China Oral Solid Dosage Pharmaceutical Formulation Breakdown Data by Company
• 8.2 China Oral Solid Dosage Pharmaceutical Formulation Breakdown Data by Type
• 8.3 China Oral Solid Dosage Pharmaceutical Formulation Breakdown Data by Application

9 Rest of World

• 9.1 Rest of World Oral Solid Dosage Pharmaceutical Formulation Breakdown Data by Company
• 9.2 Rest of World Oral Solid Dosage Pharmaceutical Formulation Breakdown Data by Type
• 9.3 Rest of World Oral Solid Dosage Pharmaceutical Formulation Breakdown Data by Application
• 9.4 Rest of World Oral Solid Dosage Pharmaceutical Formulation Breakdown Data by Countries
  • 9.4.1 Rest of World Oral Solid Dosage Pharmaceutical Formulation Sales by Countries
  • 9.4.2 Rest of World Oral Solid Dosage Pharmaceutical Formulation Revenue by Countries
  • 9.4.3 Japan
  • 9.4.4 Korea
  • 9.4.5 India
  • 9.4.6 Southeast Asia

10 Company Profiles

• 10.1 AstraZeneca
  • 10.1.1 AstraZeneca Company Details
  • 10.1.2 Company Description and Business Overview
  • 10.1.3 Sales, Revenue and Market Share of Oral Solid Dosage Pharmaceutical Formulation
  • 10.1.4 Oral Solid Dosage Pharmaceutical Formulation Product Introduction
  • 10.1.5 AstraZeneca Recent Development
• 10.2 Bristol-Myers Squibb
  • 10.2.1 Bristol-Myers Squibb Company Details
  • 10.2.2 Company Description and Business Overview
  • 10.2.3 Sales, Revenue and Market Share of Oral Solid Dosage Pharmaceutical Formulation
  • 10.2.4 Oral Solid Dosage Pharmaceutical Formulation Product Introduction
  • 10.2.5 Bristol-Myers Squibb Recent Development
• 10.3 Eli Lilly
  • 10.3.1 Eli Lilly Company Details
  • 10.3.2 Company Description and Business Overview
  • 10.3.3 Sales, Revenue and Market Share of Oral Solid Dosage Pharmaceutical Formulation
  • 10.3.4 Oral Solid Dosage Pharmaceutical Formulation Product Introduction
  • 10.3.5 Eli Lilly Recent Development
• 10.4 Gilead
  • 10.4.1 Gilead Company Details
  • 10.4.2 Company Description and Business Overview
  • 10.4.3 Sales, Revenue and Market Share of Oral Solid Dosage Pharmaceutical Formulation
  • 10.4.4 Oral Solid Dosage Pharmaceutical Formulation Product Introduction
  • 10.4.5 Gilead Recent Development
• 10.5 Merck
  • 10.5.1 Merck Company Details
  • 10.5.2 Company Description and Business Overview
  • 10.5.3 Sales, Revenue and Market Share of Oral Solid Dosage Pharmaceutical Formulation
  • 10.5.4 Oral Solid Dosage Pharmaceutical Formulation Product Introduction
  • 10.5.5 Merck Recent Development
• 10.6 Novartis
  • 10.6.1 Novartis Company Details
  • 10.6.2 Company Description and Business Overview
  • 10.6.3 Sales, Revenue and Market Share of Oral Solid Dosage Pharmaceutical Formulation
  • 10.6.4 Oral Solid Dosage Pharmaceutical Formulation Product Introduction
  • 10.6.5 Novartis Recent Development
• 10.7 Pfizer
  • 10.7.1 Pfizer Company Details
  • 10.7.2 Company Description and Business Overview
  • 10.7.3 Sales, Revenue and Market Share of Oral Solid Dosage Pharmaceutical Formulation
  • 10.7.4 Oral Solid Dosage Pharmaceutical Formulation Product Introduction
  • 10.7.5 Pfizer Recent Development
• 10.8 AbbVie
  • 10.8.1 AbbVie Company Details
  • 10.8.2 Company Description and Business Overview
  • 10.8.3 Sales, Revenue and Market Share of Oral Solid Dosage Pharmaceutical Formulation
  • 10.8.4 Oral Solid Dosage Pharmaceutical Formulation Product Introduction
  • 10.8.5 AbbVie Recent Development
• 10.9 Boehringer Ingelheim
  • 10.9.1 Boehringer Ingelheim Company Details
  • 10.9.2 Company Description and Business Overview
  • 10.9.3 Sales, Revenue and Market Share of Oral Solid Dosage Pharmaceutical Formulation
  • 10.9.4 Oral Solid Dosage Pharmaceutical Formulation Product Introduction
  • 10.9.5 Boehringer Ingelheim Recent Development

11 Value Chain and Sales Channels Analysis

• 11.1 Value Chain Analysis
• 11.2 Sales Channels Analysis
  • 11.2.1 Oral Solid Dosage Pharmaceutical Formulation Sales Channels
  • 11.2.2 Oral Solid Dosage Pharmaceutical Formulation Distributors
• 11.3 Oral Solid Dosage Pharmaceutical Formulation Customers

12 Market Forecast

• 12.1 Global Oral Solid Dosage Pharmaceutical Formulation Sales and Revenue Forecast 2019-2025
• 12.2 Global Oral Solid Dosage Pharmaceutical Formulation Sales Forecast by Type
• 12.3 Global Oral Solid Dosage Pharmaceutical Formulation Sales Forecast by Application
• 12.4 Oral Solid Dosage Pharmaceutical Formulation Forecast by Regions
  • 12.4.1 Global Oral Solid Dosage Pharmaceutical Formulation Sales Forecast by Regions 2019-2025
  • 12.4.2 Global Oral Solid Dosage Pharmaceutical Formulation Revenue Forecast by Regions 2019-2025
• 12.5 United States Market Forecast
• 12.6 European Union Market Forecast
• 12.7 China Market Forecast
• 12.8 Rest of World
  • 12.8.1 Japan
  • 12.8.2 Korea
  • 12.8.3 India

13 Research Findings and Conclusion

14 Appendix

• 14.1 Research Methodology
  • 14.1.1 Methodology/Research Approach
    • 14.1.1.1 Research Programs/Design
    • 14.1.1.2 Market Size Estimation
    • 14.1.1.3 Market Breakdown and Data Triangulation
  • 14.1.2 Data Source
    • 14.1.2.1 Secondary Sources
    • 14.1.2.2 Primary Sources
• 14.2 Author Details

Oral solid dosage forms are the most commonly used pharmaceuticals to treat various disease conditions. Oral solid dosage forms are cost-effective and easy to manufacture in comparison with other dosage forms. They offer significant benefits to manufacturers such as trouble free packaging and transportation and increased chemical and physical stability. Oral solids offer many advantages to patients as well.
North America dominated the global oral solid dosage pharmaceutical formulation market in revenue terms in 2017, and the trend is projected to continue throughout the forecast period.
In 2019, the market size of Oral Solid Dosage Pharmaceutical Formulation is xx million US$ and it will reach xx million US$ in 2025, growing at a CAGR of xx% from 2019; while in China, the market size is valued at xx million US$ and will increase to xx million US$ in 2025, with a CAGR of xx% during forecast period.
In this report, 2018 has been considered as the base year and 2019 to 2025 as the forecast period to estimate the market size for Oral Solid Dosage Pharmaceutical Formulation.

This report studies the global market size of Oral Solid Dosage Pharmaceutical Formulation, especially focuses on the key regions like United States, European Union, China, and other regions (Japan, Korea, India and Southeast Asia).
This study presents the Oral Solid Dosage Pharmaceutical Formulation sales volume, revenue, market share and growth rate for each key company, and also covers the breakdown data (sales, revenue and market share) by regions, type and applications. history breakdown data from 2014 to 2019, and forecast to 2025.
For top companies in United States, European Union and China, this report investigates and analyzes the production, value, price, market share and growth rate for the top manufacturers, key data from 2014 to 2019.

In global market, the following companies are covered:
AstraZeneca
Bristol-Myers Squibb
Eli Lilly
Gilead
Merck
Novartis
Pfizer
AbbVie
Boehringer Ingelheim

Market Segment by Product Type
Immediate Release
Extended Release
Others

Market Segment by Application
Hospital Pharmacy
Retail Pharmacy
Drug Stores
Others

Key Regions split in this report: breakdown data for each region.
United States
China
European Union
Rest of World (Japan, Korea, India and Southeast Asia)

The study objectives are:
To analyze and research the Oral Solid Dosage Pharmaceutical Formulation status and future forecast in United States, European Union and China, involving sales, value (revenue), growth rate (CAGR), market share, historical and forecast.
To present the key Oral Solid Dosage Pharmaceutical Formulation manufacturers, presenting the sales, revenue, market share, and recent development for key players.
To split the breakdown data by regions, type, companies and applications
To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
To identify significant trends, drivers, influence factors in global and regions
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market

In this study, the years considered to estimate the market size of Oral Solid Dosage Pharmaceutical Formulation are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025